InsidersTradesSigma
Explore the full record of transactions filed by Lea Leiv, 首席财务官. Director active across 1 company, notably Corvus Pharmaceuticals, Inc.. In total, 1 filings have been published. Split: 1 buy · 0 sell. Total volume traded: €49k. Activity tracked since 16 March 2022. The latest transaction was disclosed on 16 March 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Leiv Lea serves as Chief Financial Officer at Corvus Pharmaceuticals, Inc. He is responsible for the financial management of the company, including financial planning, risk management, and financial reporting. With a strong background in the pharmaceutical sector, Leiv Lea is committed to ensuring the financial health of Corvus Pharmaceuticals and supporting its strategic growth. His role is essential in ensuring compliance with financial regulations.